|Day Low/High||1.89 / 2.05|
|52 Wk Low/High||2.28 / 11.65|
Investors in Anthera Pharmaceuticals Inc. saw new options begin trading today, for the September 16th expiration.
Trade-Ideas LLC identified Anthera Pharmaceuticals (ANTH) as a weak on high relative volume candidate
Investors in Anthera Pharmaceuticals Inc. saw new options become available this week, for the August 19th expiration.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CXP, EQS, FSBK, GIG, GPT, KEYW, OKSB, PBBI, PFE, PRA, PW, RIC, SUNW Downgrades: AAME, AIRI, AVGO, COWN, CRTO, CXDC, GPIC, LIOX, MSLI, PDVW, ZFC Initiations: ANTH Read on to get TheStreet Quant Ratings' detailed report:
Investors in Anthera Pharmaceuticals Inc. saw new options begin trading this week, for the October 21st expiration.
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
The most recent short interest data has been released by the NASDAQ for the 11/30/2015 settlement date, which shows a 414,011 share increase in total short interest for Anthera Pharmaceuticals Inc. , to 3,028,450, an increase of 15.84% since 11/13/2015.
Investors in Anthera Pharmaceuticals Inc. saw new options begin trading this week, for the November 20th expiration.
Investors in Anthera Pharmaceuticals Inc. saw new options become available this week, for the April 2016 expiration.